Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Declared position

21.7%

Threshold

Crossed downwards

Timeline

Published

15.05.2012

Transaction

09.05.2012

Voting rights breakdown

Voting rights acquired1.67%

Voting rights sold21.7%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAC5E00050

Beneficial owner

ADDEX PHARMACEUTICALS LTD

Declared address

ADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

Décision de l'assemblée générale des actionnaires du 09/05/2012 approuvant la création de 400 bons de jouissance supplémentaires, déclenchant le franchissement du seuil de 20% de positions d'aliénation à la hausse.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Addex Therapeutics Ltd15.05.2012TAC5E00050

Disclosure summary

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 15.05.2012, at 21.7% of voting rights. Notice category: Single shareholder.

Disclosed position

21.7%

Voting rights sold

Voting rights acquired1.67%

Voting rights sold21.7%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd, published on 15.05.2012.

Publication date15.05.2012

Transaction date09.05.2012

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX PHARMACEUTICALS LTD

Declared addressADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired1.67%

Voting rights sold21.7%

Below threshold0%

ExchangeXSWX

Notification IDTAC5E00050

Conditions

Décision de l'assemblée générale des actionnaires du 09/05/2012 approuvant la création de 400 bons de jouissance supplémentaires, déclenchant le franchissement du seuil de 20% de positions d'aliénation à la hausse.

Source: SIX Exchange Regulation · Publication date: 15.05.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open